OBJECTIVE To estimate the prevalence of the metabolic syndrome (MS) in a population of patients with overweight and obesity of the A Coruña and Granada health areas, using the definitions of the Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (ATP III) and of the International Diabetes Federation ...

The metabolic syndrome has been documented to increase the risk of cardiovascular disease and chronic kidney disease (CKD); however, there are few studies of this in developing countries. A total of 15,357 participants of a standardized check-up, included metabolic screening, were enrolled. Metabolic syndrome was defined using criteria modified from the National Cholesterol Education Program Ad...

Abstract Background Metabolic syndrome (MetS) is a major risk factor for cardiovascular diseases. The objective of the study was to evaluate updated prevalence MetS and provide comprehensive illustration possible temporal changes in China from 2011 2015. Methods data this are 2015 waves Health Retirement Longitudinal Study (CHARLS). CHARLS nationally representative survey targeting populations ...

BACKGROUND The objective of this study was to evaluate the validity of self reported criteria of Metabolic Syndrome (MS) in the SUN (Seguimiento Universidad de Navarra) cohort using their medical records as the gold standard. METHODS We selected 336 participants and we obtained MS related data according to Adult Treatment Panel III (ATP III) and International Diabetes Federation (IDF). Then w...

The Adult Treatment Panel III (ATP III) has published criteria for diagnosing the metabolic syndrome, a cluster of closely related abnormalities related to insulin resistance that increase cardiovascular disease risk. The present analysis was performed to evaluate the ability of these criteria to identify insulin-resistant individuals. The population consisted of 443 healthy volunteers, with me...

UNLABELLED The presence of the metabolic syndrome is an important risk factor for cardiovascular disease and diabetes. There are limited data on the prevalence of the metabolic syndrome in European patients suffering from schizophrenia. METHODS All consecutive patients with schizophrenia at our university psychiatric hospital and affiliate services were entered in an extensive prospective met...

background: some evidence, not in large study populations, suggests that nonalcoholic fatty liver disease (nafld) and metabolic syndrome (mets) share common interactions. we aimed to determine the prevalence of nafld and mets in a large population registered to kavar cohort study center. we also assessed the role of each component of mets in nafld existence. methods: data were obtained from 341...

T he metabolic syndrome describes the clustering of risk factors for diabetes and cardiovascular disease (1). New Zealand Polynesians of both Maori and Pacific descent have high rates of conponents for the metabolic syndrome: type 2 diabetes (2), obesity (2), hypertension (3), dyslipidemia (4), and coronary heart disease (5,6). There have been no previous reports of the prevalence of the metabo...